Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Sativex improves spasticity in MS patients in phase III trial

June 23, 2004

5-HT reuptake inhibitors and 5-HT receptor agonists developed at Merck KGaA

June 23, 2004

Novel GABA-A receptor ligands in early development at Neurogen

June 23, 2004

ExonHit develops improved formulation of Ikomio

June 23, 2004

Guilford licenses U.S. rights to GPI-1485 to Symphony Neuro Development Company

June 22, 2004

Potent in vivo antinociceptive effects of orally active agent by Mochida

June 22, 2004

Guilford patent covers new DPPIV inhibitors and their therapeutic use

June 21, 2004

Results from confirmatory phase II study of Aquavan

June 21, 2004

Copaxone PFS available in Europe

June 21, 2004

Targeting of Nurr1 gene promising for Parkinson's disease therapy

June 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...